Grant

KronoLife Receives a TED Fund Proof-of-Concept Grant to Study New Longevity Supplements ZenoBlazt+ and ZenoGenez+

Thailand's Technology and Innovation-Based Enterprise Development Fund (TED Fund) is supporting a study of the anti-aging effects of supplements built on actives that target senescent cells.

Grant recipients holding their certificates on stage at TED Fund Grant Day 2024, Empowering Growth

KronoLife Co., Ltd., a longevity deep-tech startup affiliated with Thailand's National Science and Technology Development Agency (NSTDA), has received a proof-of-concept (POC) grant from the Technology and Innovation-Based Enterprise Development Fund, known as TED Fund, at TED Fund Grant Day 2024, held under the theme "Empowering Growth". Dr. Tawin Iempridee, Co-Founder and CEO–CTO of KronoLife, announced the grant on 15 November 2024.

What the TED Fund grant will study

The funded project studies two new KronoLife longevity supplement formulas, ZenoBlazt+ and ZenoGenez+, and their anti-aging effects in middle-aged and older adults.

Both formulas contain actives that KronoLife developed to deal with "zombie cells", the senescent cells that stop dividing but do not die, and build up with age. Cellular senescence is one of the twelve hallmarks of aging. Senescent cells accelerate aging, including visible skin aging, and drive other hallmarks of aging in turn.

ZenoBlazt and ZenoGenez

KronoLife builds its supplements on one idea: start from a mechanism of aging, then design the formula.

  • ZenoBlazt is built on the active DionySenz, a senolytic supplement that targets senescent cells.
  • ZenoGenez is built on the KronoZase complex, a geroprotector supplement for long-term health.

ZenoBlazt+ and ZenoGenez+ are the new formulas that build on these two products. The current products are described on the products page.

About the TED Fund

TED Fund supports technology and innovation entrepreneurs in Thailand. A proof-of-concept grant helps a startup test whether a technology developed in the laboratory works as designed before it moves to the next stage.

For KronoLife, studies in people are the step after results in cells and in ex vivo human skin, which the company uses as the first layer of evidence for every active. The technology page explains this ladder of evidence.

In the announcement, Dr. Tawin thanked TED Fund for supporting KronoLife.

Sources

  1. Post by Dr. Tawin Iempridee (15 November 2024, Thai)

About KronoLife

KronoLife Co., Ltd. is a longevity deep-tech startup affiliated with Thailand's National Science and Technology Development Agency (NSTDA), based at Thailand Science Park. It develops plant-derived senolytic and senomorphic actives for skincare and supplements, and designs efficacy studies on ex vivo human skin and 3D skin models.

About KronoLife

More news

ZenoLase Evanesce Prime Serum and THÉVASE ReverZase Regenerate Cream with their boxes on a white stone podium in golden light
Product · 2026

KronoLife Unveils New Packaging for ZenoLase Evanesce Prime Serum and THÉVASE by KronoLife ReverZase Regenerate Cream

A senolytic serum and a senomorphic cream in new clear-capped glass bottles and holographic boxes, designed to be used one after the other in a single routine.

Read the story
KronoLife and other award winners holding their Pathum InnoTech Awards 2025 plaques with the Governor of Pathum Thani
Award · 2025

KronoLife Receives the Pathum InnoTech Awards 2025 Outstanding Product Award from the Governor of Pathum Thani

The provincial award follows the Innovation Excellence Award KronoLife won at Pathum InnoTech Pitching 2025 in August.

Read the story
THÉVASE by KronoLife ReverZase Regenerate Cream box and bottle on a white stone podium
Event · 2025

KronoLife Signs MOUs with Avaya International and VISBIO, Launching the THÉVASE Brand and a Certification Mark for Longevity Products

The signing took place at NanoThailand 2025 under the theme "From DeepTech to Longevity Innovation".

Read the story

All news